Medaus Recalls B-Complex and Lidocaine Vials Due to Sterility Concerns
Medaus, Inc. is recalling specific lots of B-Complex with Methyl B12 and Lidocaine vials because the company cannot guarantee the product is sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or property damage reports or high-risk scenarios.
Plain-English summary
Medaus, Inc. is recalling specific lots of B-Complex with Methyl B12 and Lidocaine vials. The recall was initiated because the company lacks assurance of the product's sterility. The affected product is available in 1 mL, 5 mL, and 10 mL vials.
The recall covers 370 mL of product in vials distributed nationwide in the United States, as well as in Japan and New Zealand. Specific lot numbers and expiration dates are listed in the recall documentation.
Consumers and healthcare providers should stop using the affected vials and contact Medaus, Inc. for further instructions or a refund.
The recalled product
- Product
- B-COMPLEX W/METHYL B12/LIDO W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG, LIDOCAINE 1%, METHYL B12 1MG/ML, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY
- Manufacturer
- Medaus, Inc.
- Category
- Drug — Injectable Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- a) Lot #: 151228-62
- BUD: 06/25/16. b) Lot #: 160111-2
- BUD: 06/11/16
- Lot #: 160113-3
- Lot #: 160113-76
- Lot #: 160118-1
- Lot #: 160119-2
- Lot #: 160119-65
- Lot #: 160122-9
- Lot #: 160128-10
- Lot #: 160202-65
- Lot #: 160204-44
- Lot #: 160217-54
- Lot #: 160223-5
- Lot #: 160224-66
- Lot #: 160229-23
- Lot #: 160315-3
- BUD: 06/11/16. c) Lot #: 160118-1
- Lot #: 160127-2
- Lot #: 160210-37
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 88 recalled by Medaus, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 88 products in this recall →Related recalls
Same manufacturer · Medaus, Inc.
See all →- SevereMedaus Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Taurine Vials Due to Lack of Sterility Assurance
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Lipo-Injection Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15